Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
28.39 USD | +1.83% |
|
+2.86% | +5.03% |
Apr. 23 | Transcript : HealthStream, Inc., Q1 2024 Earnings Call, Apr 23, 2024 | |
Apr. 22 | Earnings Flash (HSTM) HEALTHSTREAM Posts Q1 Revenue $72.8M, vs. Street Est of $71.9M | MT |
Summary
- The company presents an interesting fundamental situation from a short-term investment perspective.
Strengths
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- With an expected P/E ratio at 51.06 and 47.09 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The firm pays small or no dividend to shareholders. For that reason, it is not a yield company.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Software
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+5.03% | 863M | C+ | ||
+35.41% | 393B | B- | ||
+33.68% | 235B | B+ | ||
+6.04% | 154B | B | ||
+24.63% | 63.69B | D+ | ||
+34.67% | 38.73B | C+ | ||
-15.64% | 24.96B | B+ | ||
+115.09% | 24.1B | D+ | ||
+26.00% | 22.08B | B- | ||
+5.73% | 13.74B | B |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- HSTM Stock
- Ratings HealthStream, Inc.